Macmillan Cancer Support

To add a bio or update investment portfolio, please click update information.

Investment Portfolio

Hypervision Surgical secures a £17m Series A led by Heal Capital to equip surgeons with next-gen tissue imaging

29 Apr 2026

Hypervision Surgical secures a £17m Series A led by Heal Capital to equip surgeons with next-gen tissue imaging

Hypervision Surgical develops imaging technology that provides real-time insights into tissue during surgery. Its platform enables surgeons to assess tissue physiology beyond what is visible to the human eye, supporting intraoperative decision-making.

Lucida Medical

30 Mar 2026

Lucida Medical secures £8.7m in funding led by IW Capital to detect early prostate cancer in scans with AI

Lucida Medical develops software to help clinicians detect prostate cancer from MRI scans. It analyses scans to highlight suspicious areas and support faster and more consistent diagnostic decisions.

Infinitopes

21 Jan 2026

Infinitopes secures an £11m seed round led by Octopus Ventures and Amplify Bio to prevent recurrence of oesophageal cancer

Infinitopes develops off-the-shelf precision cancer vaccines designed to prevent recurrence, using AI-powered immunomics to target shared tumour features and advance new immunotherapies into clinical trials.

Perci Health

11 Jun 2025

Perci Health secures £3m from UK venture funds and Macmillan Cancer Support to scale virtual cancer clinic

Perci Health runs a virtual cancer clinic that combines digital tools with multidisciplinary specialist care, supporting patients through treatment, recovery and survivorship while addressing gaps in long-term cancer care provision.

52North

6 Dec 2024

Oncology medical tech startup 52North secures £5m with landmark UK-US hospital VC deal

52North builds medical devices and digital tools that support cancer patients outside hospital, focusing on early detection and monitoring of treatment-related complications to improve urgent oncology care pathways.

Macmillan Cancer Support